Roel de Weger

5.0k total citations · 1 hit paper
23 papers, 3.7k citations indexed

About

Roel de Weger is a scholar working on Molecular Biology, Immunology and Cancer Research. According to data from OpenAlex, Roel de Weger has authored 23 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 8 papers in Immunology and 8 papers in Cancer Research. Recurrent topics in Roel de Weger's work include MicroRNA in disease regulation (4 papers), Immunotherapy and Immune Responses (4 papers) and Virus-based gene therapy research (3 papers). Roel de Weger is often cited by papers focused on MicroRNA in disease regulation (4 papers), Immunotherapy and Immune Responses (4 papers) and Virus-based gene therapy research (3 papers). Roel de Weger collaborates with scholars based in Netherlands, Germany and United States. Roel de Weger's co-authors include Dick van Wichen, Hans Clevers, Nick Barker, Patrice J. Morin, Bert Vogelstein, Kenneth W. Kinzler, Vladimír Kořínek, Joyce van Kuik, Hamid el Azzouzi and Stefanos Leptidis and has published in prestigious journals such as Science, Blood and PLoS ONE.

In The Last Decade

Roel de Weger

21 papers receiving 3.6k citations

Hit Papers

Constitutive Transcriptional Activation by a β-Catenin-Tc... 1997 2026 2006 2016 1997 500 1000 1.5k 2.0k 2.5k

Peers

Roel de Weger
Joshua P. Frederick United States
Dick van Wichen Netherlands
Lucio H. Castilla United States
Luke B. Hesson Australia
Anita J. Merritt United Kingdom
Ferenc Boldog United States
Joshua P. Frederick United States
Roel de Weger
Citations per year, relative to Roel de Weger Roel de Weger (= 1×) peers Joshua P. Frederick

Countries citing papers authored by Roel de Weger

Since Specialization
Citations

This map shows the geographic impact of Roel de Weger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roel de Weger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roel de Weger more than expected).

Fields of papers citing papers by Roel de Weger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roel de Weger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roel de Weger. The network helps show where Roel de Weger may publish in the future.

Co-authorship network of co-authors of Roel de Weger

This figure shows the co-authorship network connecting the top 25 collaborators of Roel de Weger. A scholar is included among the top collaborators of Roel de Weger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roel de Weger. Roel de Weger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hoogen, Patricia van den, Manon M. H. Huibers, Roel de Weger, et al.. (2022). Elevated Plasma Immunoglobulin Levels Prior to Heart Transplantation Are Associated with Poor Post-Transplantation Survival. Biology. 12(1). 61–61.
2.
Lei, Zhiyong, Christine Wahlquist, Hamid el Azzouzi, et al.. (2021). miR-132/212 Impairs Cardiomyocytes Contractility in the Failing Heart by Suppressing SERCA2a. Frontiers in Cardiovascular Medicine. 8. 592362–592362. 25 indexed citations
3.
Kuik, Joyce van, et al.. (2017). Preanalytical blood sample workup for cell‐free DNA analysis using Droplet Digital PCR for future molecular cancer diagnostics. Cancer Medicine. 6(10). 2297–2307. 78 indexed citations
4.
Vink, Aryan, et al.. (2017). Liquid Biopsies: Non-Invasive Rejection Detection After Heart Transplantation. The Journal of Heart and Lung Transplantation. 36(4). S136–S136. 2 indexed citations
5.
Hogenes, M. C. H., et al.. (2014). Humanized mouse models in transplantation research. Transplantation Reviews. 28(3). 103–110. 17 indexed citations
6.
Leptidis, Stefanos, Hamid el Azzouzi, Sjoukje I. Lok, et al.. (2013). Correction: A Deep Sequencing Approach to Uncover the miRNOME in the Human Heart. PLoS ONE. 8(6). 13 indexed citations
7.
Huibers, Manon M. H., Nicolaas de Jonge, Joyce van Kuik, et al.. (2011). Intimal fibrosis in human cardiac allograft vasculopathy. Transplant Immunology. 25(2-3). 124–132. 29 indexed citations
8.
Resemann, Henrike K., Liane te Boome, Debbie van Baarle, et al.. (2011). The immunological phenotype of rituximab-sensitive chronic graft-versus-host disease: a phase II study. Haematologica. 96(9). 1380–1384. 11 indexed citations
9.
Thunnissen, Erik, Judith V.M.G. Bovée, Adriaan J. C. van den Brule, et al.. (2011). EGFR and KRAS quality assurance schemes in pathology: generating normative data for molecular predictive marker analysis in targeted therapy. Journal of Clinical Pathology. 64(10). 884–892. 27 indexed citations
10.
Martins, Paula A. da Costa, Kanita Salic, Monika M Gladka, et al.. (2010). MicroRNA-199b targets the nuclear kinase Dyrk1a in an auto-amplification loop promoting calcineurin/NFAT signalling. Nature Cell Biology. 12(12). 1220–1227. 257 indexed citations
11.
Rhijn, Ildiko Van, Rachel Spiering, Roel de Weger, et al.. (2007). Highly diverse TCR δ chain repertoire in bovine tissues due to the use of up to four D segments per δ chain. Molecular Immunology. 44(12). 3155–3161. 22 indexed citations
12.
Weijtens, Mo, Anke van Spronsen, Anton Hagenbeek, Roel de Weger, & Anton C. Martens. (2004). Ganciclovir-mediated elimination of HSV-Tk+ T cells and cure of graft-vs-host disease in an allogeneic bone marrow transplantation model in the rat. Experimental Hematology. 32(10). 962–969. 2 indexed citations
13.
Weijtens, Mo, Anton Hagenbeek, Anke van Spronsen, et al.. (2003). Monitoring of Developing Graft-Versus-Host Disease Mediated by Herpes Simplex Virus Thymidine Kinase Gene-Transduced T Cells. Human Gene Therapy. 14(4). 341–351. 4 indexed citations
14.
Bakema, Jantine E., et al.. (2000). Detection of a putativeHLA-A*31012 processed (intronless) pseudogene in a laryngeal squamous cell carcinoma. Genes Chromosomes and Cancer. 27(1). 26–34. 13 indexed citations
16.
Rozemuller, Erik H., et al.. (1999). Mutation in the β2m gene is not a frequent event in head and neck squamous cell carcinomas. Human Immunology. 60(8). 697–706. 27 indexed citations
17.
Veltkamp, Marcel, Joyce van Kuik, Selma P. Wiertsema, et al.. (1999). HLA class I expression and chromosomal deletions at 6p and 15q in head and neck squamous cell carcinomas. Tissue Antigens. 54(3). 235–245. 81 indexed citations
18.
Kořínek, Vladimír, Nick Barker, Patrice J. Morin, et al.. (1997). Constitutive Transcriptional Activation by a β-Catenin-Tcf Complex in APC −/− Colon Carcinoma. Science. 275(5307). 1784–1787. 2856 indexed citations breakdown →
19.
Castrop, Jan, Dick van Wichen, Marc van de Wetering, et al.. (1995). The human TCF-1 gene encodes a nuclear DNA-binding protein uniquely expressed in normal and neoplastic T-lineage lymphocytes. Blood. 86(8). 3050–3059. 47 indexed citations
20.
Giltay, Jacques C., et al.. (1991). [Molecular genetic aspects of phenylketonuria (PKU)].. PubMed. 59(3). 77–80. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026